The effect of bromocriptine (BCT) on the on-off phenomenon
- 1 March 1981
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 52 (1-2) , 41-47
- https://doi.org/10.1007/bf01253095
Abstract
Twenty-three patients with idiopathic Parkinson disease with classic “on-off” phenomena were studied prospectively during treatment with bromocriptine (BCT). Patients were evaluated for an average of 6 to 12 months and received an average of 56.5 mg of BCT. Nine patients (39%) showed improvement in terms of “on-off”. When evaluated retrospectively, it appeared that the only difference between the responders and nonresponders was a younger mean age (57.1 to 63.2).This publication has 10 references indexed in Scilit:
- Long‐term efficacy of bromocriptine in Parkinson diseaseNeurology, 1980
- The role of bromocriptine in the treatment of parkinsonismNeurology, 1979
- Bromocriptine in Parkinson diseaseNeurology, 1979
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978
- Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISMThe Lancet, 1976
- Studies with bromocriptine Part 1. “On‐off” phenomenaNeurology, 1976
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- ParkinsonismNeurology, 1967